98%
921
2 minutes
20
Prostatic calculi are common and are associated with inflammation of the prostate. Recently, it has been suggested that this inflammation may be associated with prostate carcinogenesis. The aim of this study was to investigate the relationship between prostatic calculi and prostate cancer (PCa) in prostate biopsy specimens. We retrospectively analyzed 417 consecutive patients who underwent transrectal ultrasonography (TRUS) and prostate biopsies between January 2005 and January 2008. Based on the biopsy findings, patients were divided into benign prostatic hyperplasia and PCa groups. TRUS was used to detect prostatic calculi and to measure prostate volume. The correlations between PCa risk and age, serum total PSA levels, prostate volume, and prostatic calculi were analyzed. Patient age and PSA, as well as the frequency of prostatic calculi in the biopsy specimens, differed significantly between both the groups (P < 0.05). In the PCa group, the Gleason scores (GSs) were higher in patients with prostatic calculi than in patients without prostatic calculi (P = 0.023). Using multivariate logistic regression analysis, we found that patient age, serum total PSA and prostate volume were risk factors for PCa (P = 0.001), but that the presence of prostatic calculi was not associated with an increased risk of PCa (P = 0.13). In conclusion, although the presence of prostatic calculi was not shown to be a risk factor for PCa, prostatic calculi were more common in patients with PCa and were associated with a higher GS among these men.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3739099 | PMC |
http://dx.doi.org/10.1038/aja.2009.86 | DOI Listing |
Zhonghua Nan Ke Xue
July 2025
Department of Urology, Baoji People's Hospital Affiliated to Yan'an University, Baoji, Shaanxi 721000, China.
Objective: To analyze the symptoms, diagnosis and treatment of upper urinary tract calculi patients combined with mild and moderate benign prostatic hyperplasia (BPH) after ureteral stent implantation. Methods: One hundred and six BPH patients who were hospitalized for upper urinary tract calculi and had ureteral stents retained from January 2019 to December 2022 were selected and divided into 2 weeks group and 4 weeks group according to the time of removal of ureteral stents after surgery. Their general clinical data were analyzed and compared.
View Article and Find Full Text PDFCan J Urol
August 2025
Department of Urology, Mayo Clinic, Rochester, MN 55905, USA.
While cystolitholapaxy for bladder stones is commonly performed using a transurethral approach, large or complex stone burdens in patients with complex lower urinary tract anatomy may make this inefficient or infeasible. Percutaneous cystolitholapaxy is a safe, effective, minimally invasive alternative for diverse indications, including patients with benign prostatic hyperplasia, urethral stricture disease, closed bladder neck, continent catheterized channel, or other urinary diversion. In this article, we review the indications for and advantages of percutaneous cystolitholapaxy and describe our step-by-step technique for this procedure, including representative imaging and favored equipment.
View Article and Find Full Text PDFZhonghua Nan Ke Xue
April 2025
Department of Urology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, 450000, China.
Objective: The aim of this study is to investigate the independent risk factors of benign prostatic hyperplasia (BPH) complicated with bladder stones, and construct a nomogram prediction model for clinical progression of bladder stones in patients with BPH.
Methods: The clinical data of 368 BPH patients who underwent transurethral resection of the prostate in the Second Affiliated Hospital of Zhengzhou University from January 2018 to January 2021 were retrospectively analyzed. Patients with BPH were divided into group 1 (with bladder stones, n=94) and group 2 (without bladder stones, n=274).
Cureus
June 2025
Urology, Grant Government Medical College and Sir JJ Group of Hospitals, Mumbai, IND.
Xanthogranulomatous prostatitis (XGP) is a rare chronic inflammatory condition of the prostate that can clinically and radiologically mimic prostate cancer (PCa). We present a case of XGP in an elderly male with markedly elevated prostate-specific antigen (PSA) levels and imaging findings suggestive of locally advanced PCa. A 66-year-old male with a two-month history of intermittent fever was incidentally found to have two vesical calculi (13 mm and 9 mm) and grade 3 prostatomegaly (57 cc) with a large median lobe.
View Article and Find Full Text PDFJAMA
September 2025
Department of Urology, University of Michigan, Ann Arbor.